Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(7 sites)

United States

Ascendis Pharma Investigational Site, Centennial, Colorado

Ascendis Pharma Investigational Site, Orlando, Florida

Ascendis Pharma Investigational Site, Atlanta, Georgia

Ascendis Pharma Investigational Site, Idaho Falls, Idaho

Ascendis Pharma Investigational Site, Saint Paul, Minnesota

Ascendis Pharma Investigational Site, Oklahoma City, Oklahoma

Ascendis Pharma Investigational Site, San Antonio, Texas